North America Holds Around 37% Of The Market Share For Influenza Diagnostics.

Demand for rapid influenza diagnostic testing (RIDT) is projected to reach a valuation of US$ 2 Bn by 2031, surging at a CAGR of 6%, while that for RT-PCR is set to increase at 5%.

Fact.MR, a market research and competitive intelligence provider: The global Influenza Diagnostics market reached a valuation of US$ 2.5 Bn in 2020, and is anticipated to top US$ 4 Bn by 2031, expanding at a CAGR of 5%. Demand for rapid influenza diagnostic testing (RIDT) is projected to reach a valuation of US$ 2 Bn by 2031, surging at a CAGR of 6%, while that for RT-PCR is set to increase at 5%.

North America influenza diagnostic tests market is anticipated to reach over USD 1,131 million by 2028 owing to the increasing prevalence of influenza, growing awareness regarding disease diagnosis & treatment, and the presence of major market players among others.

Factors such as increasing prevalence of influenza, growing awareness for early detection using specific diagnostic tests, development of CLIA-waived POC molecular influenza tests, and shifting focus from centralized laboratories to decentralized point-of-care testing are expected to propel the growth of the global market over the coming years.

For more insights into the Market, Get A Sample of this Report!

https://www.factmr.com/connectus/sample?flag=S&rep_id=6682

Key Takeaways from Market Study

Increasing awareness among the global population regarding the importance of early disease detection is a major factor responsible for the growth of the global market for influenza diagnostics. Owing to this, organizations are taking initiatives to promote early diagnosis practice to prevent and eradicate mortality due to the disease. For instance:

For Comprehensive Insights Ask An Analyst Here

https://www.factmr.com/connectus/sample?flag=AE&rep_id=6682

Key Segments Covered in Influenza Diagnostics Industry Research

Some major findings of the influenza diagnostic tests market report include:

Key Points Covered in Influenza Diagnostics Industry Survey:

Get Customization on this Report for Specific Research Solutions

https://www.factmr.com/connectus/sample?flag=RC&rep_id=6682

Fact.MR, in its new offering, presents an unbiased analysis of the Influenza Diagnostics Market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2032.

The study divulges essential insights on the market on the basis of Test (Traditional Influenza Diagnostic Tests, Molecular Influenza Diagnostic Tests), By End User, Global Insights 2021 to 2031, across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

Check out more studies related to Healthcare Industry, conducted by Fact.MR:

Cardiogenic Shock Market - Cardiogenic shock treatment accounts for nearly 6.4% share of the global cardiovascular device market, which was estimated to be around US$ 51.9 Bn in 2021.

Bone Grafts and Substitutes Market - The global bone grafts and substitutes market reached a valuation of US$ 3.06 Bn in 2020. Sales of bone grafts and substitutes are slated to rise at a CAGR of 4.9% to reach US$ 4.44 Bn by the end of 2028.

Medical Waste Management Market - The global medical waste management market, which projects market growth at a CAGR of 6.2% from 2021 to 2028. Revenue from medical waste management services accounted for US$ 15.3 Bn in 2020, and is estimated to surge to US$ 25.2 Bn by the end of 2028.

Gene Therapy Market - The global gene therapy market is slated to acquire a valuation of US$ 1.85 Billion in 2022, up from US$ 1.55 Billion in 2021, representing a Y-o-Y increase of 19.3%. From 2022-2032, the market is poised to register a CAGR of 18.5%, reaching a valuation of US$ 10.1 Billion.

Drug Delivery Systems Market - Demand for self-administration and home health care devices is expected to drive growth in the worldwide drug delivery systems market from 2022 to 2032.

Antibody Drug Conjugates Contract Market - The Antibody Drug Conjugates Contract Market is accounted to give an absolute dollar opportunity growth of nearly US$ 29.7 Bn during 2022 – 2032. Myeloma is expected to be the highest revenue-generating condition type.

Cochlear Implant Market - The global sales of Cochlear Implant Market in 2021 was held at US$ 2.2Bn. With 14.1%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth. Unilateral Implants are expected to be the highest revenue generating segment, projected to grow at a CAGR of over 14.3% during 2022 – 2032.

Lateral Flow Assays Market - Benchtop Readers is expected to be the highest revenue generating product, while Clinical Testing is considered to be the highest revenue generating application with a CAGR of 4.6% and 5% respectively during 2022 – 2032.

Ophthalmic Ultrasound Devices Market - The global sales of Ophthalmic Ultrasound Devices Market in 2021 was held at US$ 432.2 Mn. With 9.0%, the projected market growth during 2022 - 2032 is expected to be significantly higher than the historical growth.

Reprocessed Medical Devices Market - The consumption of reprocessed medical devices to rise at an impressive CAGR of 14.9% from 2021 to 2028. In 2020, the global reprocessed medical devices market was worth US$ 2.05 Bn, and the market is anticipated to surge to a valuation of US$ 5.9 Bn by the end of 2028.

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

© 1985 - 2022 BioSpace.com. All rights reserved. Powered by Madgex Job Board Software